clindamycin-2-phosphate (Clindets)

Subscribe to Selected New Research on clindamycin-2-phosphate

126 relevant articles (14 outcomes, 28 trials/studies) found for this Drug

Also Known As:

Clindets; Cleocin phosphate; Clindesse; clindamycin phosphate

Relationship Network

Drug Context: Research Results

Heterocyclic Compounds: 23

1-Ring Heterocyclic Compounds

Pyrrolidines: 4

Lincomycin: 364

Clindamycin: 1956

clindamycin-2-phosphate: 126

clindamycin-2-phosphate: 126

Experts

1.	Wortzman, Mitchell: 2 articles (08/2008 - 06/2007)
2.	Leyden, James J: 1 article (08/2008)
3.	Godin, B: 1 article (05/2008)
4.	Ainbinder, D: 1 article (05/2008)
5.	Leibovici, V: 1 article (05/2008)
6.	Shumilov, M: 1 article (05/2008)
7.	Bishouty, N: 1 article (05/2008)
8.	Shouval, R: 1 article (05/2008)
9.	Touitou, E: 1 article (05/2008)
10.	Ingber, A: 1 article (05/2008)

Related Diseases

1.	Acne Vulgaris 05/01/1981 - "One percent clindamycin phosphate in equal parts of alcohol and water is apparently beneficial for some, but not for all patients with inflammatory acne." 01/01/2005 - "The safety and efficacy of clindamycin phosphate foam 1% versus clindamycin phosphate topical gel 1% for the treatment of acne vulgaris." 09/01/1986 - "The efficacy and skin tolerance of 1 percent clindamycin phosphate lotion were compared with those of the placebo for the lotion in a randomized, double-blind, 12-week study in forty-six patients with moderate to severe acne vulgaris" 08/01/1986 - "Thirty-two patients with acne completed a randomized, double-blind study using topical 1% clindamycin phosphate or its vehicle applied twice daily for 8 weeks for a study of its effects on the intestinal microflora" 10/15/1985 - "In an open study, 34 male and 16 female patients suffering from mild up to severe acne vulgaris were treated with topical clindamycin-phosphate over a period of 8 weeks" Get all the results and reference details, order at left...
2.	Infection 08/01/1982 - "Clinical evaluation of clindamycin-2-phosphate in the treatment of various otorhinolaryngological infections--a multi-center study using an identical protocol]" 01/01/1986 - "Clindamycin phosphate (CLDM) was administered to 33 surgical cases in orthopedics to treat or prevent infection (600 mg in 15 cases and 1,200 mg in 18 cases by intravenous drip infusion over 60 minutes) and the concentrations of CLDM in the bone marrow blood and tissue of the operative field as well as in venous blood were determined with the cup plate method of bioassay by collecting specimens immediately after completion of infusion or 30 or 60 minutes later" 07/01/1981 - "The other patients received one infection of 300 mg of clindamycin phosphate 30 min to 1 h before surgery" 09/01/1977 - "The treatment of abdominal and gynaecological infections with parenteral clindamycin phosphate." 05/01/1977 - "Clinical application of clindamycin-2-phosphate to otorhinolaryngological infections (author's transl)]" Get all the results and reference details, order at left...
3.	Bacterial Vaginosis 07/01/1990 - "Blinded intravaginal clindamycin phosphate treatment cured bacterial vaginosis in 93.5% (43 of 46) of patients 4-7 days after therapy, compared with 25.0% (four of 16) of patients receiving placebo (P less than .001)" 06/01/1995 - "In recent clinical studies, clindamycin phosphate cream administered intravaginally has been shown to be efficacious in the treatment of bacterial vaginosis (BV)" 01/01/2000 - "To asses the efficiency of the 2% clindamycin phosphate creme given in 3 and 7 daily courses officially designer for the treatment of bacterial vaginosis (BV)" 07/01/1990 - "Bacterial vaginosis: treatment with topical intravaginal clindamycin phosphate." 10/01/2001 - "STUDY DESIGN: In this double-blind, randomized multicenter study, nonpregnant women 16 years of age or older with symptomatic bacterial vaginosis were assigned to receive either 2% clindamycin phosphate vaginal cream or triple sulfonamide vaginal cream for 7 days" Get all the results and reference details, order at left...
4.	Pseudomembranous Enterocolitis (Pseudomembranous Colitis) 05/01/1986 - "Pseudomembranous colitis was observed on two occasions in the same patient and was associated with the topical administration of clindamycin phosphate" 05/01/1986 - "Pseudomembranous colitis caused by topical clindamycin phosphate." 11/01/1997 - "Fulminant pseudomembranous colitis caused by clindamycin phosphate vaginal cream." 03/17/1975 - "Two patients with diarrhea and pseudomembranous colitis associated with lincomycin hydrochloride monohydrate and clindamycin phosphate therapy were treated with cholestyramine resin, with prompt remission of symptoms." Get all the results and reference details, order at left...
5.	Diarrhea 03/01/1998 - "CONCLUSIONS: This report indicates clindamycin phosphate vaginal cream as the most probable cause of CDIC due to the temporal relationship between the occurrence of diarrhea and clindamycin administration, lack of concomitant medications, and documentation of C" 03/17/1975 - "Two patients with diarrhea and pseudomembranous colitis associated with lincomycin hydrochloride monohydrate and clindamycin phosphate therapy were treated with cholestyramine resin, with prompt remission of symptoms." Get all the results and reference details, order at left...
46 Diseases and 126 more articles analyzed in the Research Interface, order at left...

Related Drugs and Biologics

1.	Tretinoin (Retinoic Acid)
2.	clindamycin phosphate - tretinoin formulation
3.	Clindamycin (Cleocin)
4.	Tetracycline (Achromycin)
5.	Tobramycin (Nebcin)
6.	Lincomycin (Lincocin)
7.	Cefoxitin (Cefoxitin Sodium)
8.	Cholestyramine (Questran)
9.	Minocycline (Cyclops)
10.	Aminoglycosides
166 Drugs and Important Bio-Agents and 84 more articles analyzed in the Research Interface, order at left...

Related Therapies and Procedures

1.	Stents
2.	Orthopedic Procedures
3.	Gynecologic Surgical Procedures (Gynecologic Surgery)
4.	Continuous Ambulatory Peritoneal Dialysis (CAPD)
5.	Laparotomy
7 Therapies and Procedures and 7 more articles analyzed in the Research Interface, order at left...

Research Interface

Rapidly retrieve summaries of all the evidence for any disease in seconds. Save hours of search and analysis time. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time.

Unlimited Disease, Drug and Therapy Search
2 clicks from Disease to Drug to Evidence
Trial References
All the Positive Outcomes
Detailed Relationship Timeline Charts
Full Article Reference Details
Includes Mobile Interface Subscription
One-click to FDA Products/Patents
Request Institution License details >>

Price:

$490.00 access via web interface, 1 year subscription

Proceed to Checkout >>

Mobile Interface

Retrieve summaries of all the evidence for any disease from your Mobile Phone or PDA. Accelerate decision making in the field. Speed up your study of new drug and disease domains. Refresh your knowledge on the road.

Access from any web enabled PDA or Phone
Trial references
All the Positive Outcomes
Drug and Therapy searches
Full Article Reference Details
Try Mobile Interface >>

Price:

$45.00 access via "curehunter.com/m", 1 year subscription

Proceed to Checkout >>